Lovenox 30 mg/.3mL (Enoxaparin Sodium INJECTION) 30 mg/.3mL

Lovenox 30 mg/0.3mL is a subcutaneous injection containing enoxaparin sodium. It is commonly used for blood clot prevention and treatment, offering a convenient 10-syringe pack for easy administration.

Strength

30 mg/.3mL

Pack Size

10 CELLO PACK in 1 CARTON (0075-8013-10) / 1 SYRINGE in 1 CELLO PACK / .3 mL in 1 SYRINGE (0075-801

Manufacturer / TM Owner

Sanofi-Aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lovenox 30 mg/0.3mL is primarily used to prevent and treat blood clots, such as deep vein thrombosis (DVT) and pulmonary embolism. It may also be used during certain medical procedures or surgeries to reduce the risk of clot formation. This medication is often prescribed for patients who are at risk of developing clots due to prolonged immobility or other medical conditions.

Side Effects

Common effects of Lovenox 30 mg/0.3mL may include bruising, redness, or mild pain at the injection site. Some users might experience minor bleeding or allergic reactions. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Lovenox 30 mg/0.3mL should be handled with care to avoid contamination. Store it at room temperature and protect from light. Always follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not use if the solution appears discolored or contains particles.

Avoid Interactions

Lovenox 30 mg/0.3mL may interact with other blood-thinning medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be limited as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Lovenox 30 mg/0.3mL is used to prevent and treat blood clots, such as deep vein thrombosis and pulmonary embolism.

Lovenox 30 mg/0.3mL is administered via subcutaneous injection, typically into the abdomen or thigh.

Common side effects include bruising, redness, or mild pain at the injection site, and minor bleeding.

Consult a healthcare provider before using Lovenox 30 mg/0.3mL during pregnancy, as individual circumstances may vary.

Store Lovenox 30 mg/0.3mL at room temperature and protect from light. Keep it out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.